-
1دورية أكاديمية
المؤلفون: Zbigniew Doniec, Magdalena Olszanecka-Glinianowicz, Piotr Hantulik, Agnieszka Almgren-Rachtan, Jerzy Chudek
المصدر: Applied Sciences, Vol 12, Iss 23, p 12142 (2022)
مصطلحات موضوعية: chronic obstructive pulmonary disease, fix-dose salmeterol/fluticasone propionate combination, generic, Technology, Engineering (General). Civil engineering (General), TA1-2040, Biology (General), QH301-705.5, Physics, QC1-999, Chemistry, QD1-999
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Detournay, B., Pribil, C., Jourdanne, C., Price, M.
المصدر: The European Journal of Health Economics, 2002 Jan 01. 3(3), 149-155.
URL الوصول: https://www.jstor.org/stable/3570112
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5
المؤلفون: Anni Turpeinen, Anita Happonen, Jussi Haikarainen, Patrik Eriksson, Johanna Husman-Piirainen
المصدر: Journal of Aerosol Medicine and Pulmonary Drug Delivery
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Pharmaceutical Science, Pulmonary disease, fine particle dose, 030226 pharmacology & pharmacy, salmeterol–fluticasone propionate, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Robustness (computer science), Internal medicine, Administration, Inhalation, Medicine, COPD, Humans, Pharmacology (medical), Dosing, Asthma, Original Research, Salmeterol+fluticasone propionate, business.industry, Dry Powder Inhalers, asthma, medicine.disease, Registered trademark, Dry-powder inhaler, Fluticasone-Salmeterol Drug Combination, respiratory tract diseases, Bronchodilator Agents, Easyhaler, 030228 respiratory system, delivered dose, business, human activities
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7183141a696bbfa19108db288d57ce
http://europepmc.org/articles/PMC8219197 -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8
المؤلفون: Tor Biering-Sørensen, Howraman Meteran, Anders Løkke, Mohamad Isam Saeed, Jens-Ulrik Stæhr Jensen, Imane Achir, Josefin Eklöf, Filip K. Knop, Pradeesh Sivapalan
المصدر: Saeed, M I, Eklöf, J, Achir, I, Sivapalan, P, Meteran, H, Løkke, A, Biering-Sørensen, T, Knop, F K & Jensen, J U S 2020, ' Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease ', Diabetes, Obesity and Metabolism, vol. 22, no. 8, pp. 1348-1356 . https://doi.org/10.1111/dom.14040
Saeed, M I, Eklof, J, Achir, I, Sivapalan, P, Meteran, H, Lokke, A, Biering-Sørensen, T, Knop, F K & Jensen, J-U S 2020, ' Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease ', Diabetes, Obesity and Metabolism, vol. 22, no. 8, pp. 1348-1356 . https://doi.org/10.1111/dom.14040مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, dose-response relationship, pharmaco-epidemiology, cohort study, database research, dose-response relationship, observational study, pharmaco-epidemiology, type 2 diabetes, Cohort Studies, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, SALMETEROL, 0302 clinical medicine, Endocrinology, Adrenal Cortex Hormones, Diabetes mellitus, Internal medicine, Administration, Inhalation, cohort study, Internal Medicine, COPD, Humans, Medicine, database research, business.industry, Proportional hazards model, Hazard ratio, medicine.disease, Confidence interval, EXACERBATIONS, SALMETEROL/FLUTICASONE PROPIONATE, Diabetes Mellitus, Type 2, ONSET, SURVIVAL, observational study, type 2 diabetes, business, Body mass index, Cohort study
وصف الملف: application/pdf
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10
المؤلفون: Aran, Singanayagam, Nicholas, Glanville, Jason L, Girkin, Yee Man, Ching, Andrea, Marcellini, James D, Porter, Marie, Toussaint, Ross P, Walton, Lydia J, Finney, Julia, Aniscenko, Jie, Zhu, Maria-Belen, Trujillo-Torralbo, Maria Adelaide, Calderazzo, Chris, Grainge, Su-Ling, Loo, Punnam Chander, Veerati, Prabuddha S, Pathinayake, Kristy S, Nichol, Andrew T, Reid, Phillip L, James, Roberto, Solari, Peter A B, Wark, Darryl A, Knight, Miriam F, Moffatt, William O, Cookson, Michael R, Edwards, Patrick, Mallia, Nathan W, Bartlett, Sebastian L, Johnston
المساهمون: Wellcome Trust, British Medical Association, British Lung Foundation, National Institute for Health Research, The Academy of Medical Sciences, Imperial College Healthcare NHS Trust- BRC Funding, Asthma UK
المصدر: Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
Nature Communicationsمصطلحات موضوعية: 0301 basic medicine, AIRWAY INFLAMMATION, Rhinovirus, NF-KAPPA-B, General Physics and Astronomy, Receptor, Interferon alpha-beta, medicine.disease_cause, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Interferon, Adrenal Cortex Hormones, lcsh:Science, Lung, Mice, Knockout, COPD, Multidisciplinary, FLUTICASONE PROPIONATE, Bacterial Infections, Multidisciplinary Sciences, INDUCED ASTHMA, Science & Technology - Other Topics, medicine.drug, Science, OBSTRUCTIVE PULMONARY-DISEASE, Article, General Biochemistry, Genetics and Molecular Biology, Cell Line, 03 medical and health sciences, Immune system, Immunity, Administration, Inhalation, medicine, BRONCHIAL EPITHELIAL-CELLS, Animals, Humans, Antimicrobial peptide secretion, Science & Technology, Picornaviridae Infections, business.industry, EXPERIMENTAL RHINOVIRUS INFECTION, General Chemistry, medicine.disease, ANTIMICROBIAL PEPTIDES, Mucus, Bacterial Load, Immunity, Innate, respiratory tract diseases, Pneumonia, 030104 developmental biology, SALMETEROL/FLUTICASONE PROPIONATE, 030228 respiratory system, Immunology, Fluticasone, lcsh:Q, IFN-BETA, business
Full Text Finder 
Find this article in full text from Springer Verlag.